Scienza Health is a clinical technology company that builds digitalhumanOS™ and GIA®, a FDA-registered Digital Human® that screens for 46 cognitive, behavioral, and neurological conditions from a single conversation. Founded in 2024 in Newport Beach, California. GIA® analyzes 2,500+ speech biomarkers from a 40-second conversation with results in under 2 minutes. Deployed in clinical, post-acute, and workforce settings. Integrated with PointClickCare, Epic, Cerner, and MatrixCare. GIA® screens. She does not diagnose. A clinician reviews every result. Clinically validated across 19 peer-reviewed studies from institutions including Beth Israel Deaconess Medical Center, NIH, and MIT.
digitalhumanOS™ is the multimodal clinical screening operating system that powers GIA®, the Digital Human®. GIA® screens through video, voice, or landline from a 40-second conversation, with results in under 2 minutes. A clinician reviews and approves every result before it enters the clinical record. Deployed on Samsung Health Grade Galaxy devices secured by Samsung Knox. FDA-registered. HIPAA compliant.
GIA® Clinical AI Screening | 46 Conditions | Under 5 Minutes
An AI co-clinician purpose-built for cognitive and behavioral health — closing gaps before they become missed moments.
Google calls it triadic care.
GIA® has been doing it since 2024.
In May 2026, Google DeepMind announced research into AI co-clinicians — AI agents that see patients under the clinical authority of their physician. GIA® is the first commercially deployed AI co-clinician for cognitive and behavioral health. Not a research project. Live. In production today. Google DeepMind's research is titled Towards Conversational Medical AI with Eyes, Ears and a Voice. GIA® already has all three. Voice biomarker analysis. Computer vision. Natural conversation. Multimodal clinical intelligence — deployed today. Read the Google DeepMind announcement →
The screening that fits the visit already happening.
Detect decline between visits.
GIA® gives you objective signals between appointments — tracking cognitive and neurological change before it becomes clinically obvious.
PRIMARY CAREScreen before the visit starts.
GIA® screens for cognitive and behavioral risk before or between visits — without extending appointment time. Results in your EHR before you walk in.
The gaps GIA® closes.
patients leave with an undetected condition
NEJMof clinician time spent on documentation, not patients
AMA Burnout Reportlost annually to missed diagnoses in U.S. post-acute care
Johns Hopkins / BMJ Quality & Safetyaverage face time with a patient before the next one is waiting
Annals of Internal MedicineEvery handoff between your clinical team is a moment where something can go wrong. A missed follow-up. A lost intake form. A patient who declined between visits. GIA® closes the loop — so nothing falls through.
One continuous loop. No handoffs. No leakage.
GIA® handles everything before and after the encounter — so your team focuses on what only they can do. Results are ready for clinician review in under 2 minutes and write back automatically. GIA® screens. Clinicians review. Humans stay in control.
We keep humans in the loop. Always.
GIA® screens. The results appear in your EHR. Your clinician reviews and submits.
Every result reviewed by a human before it becomes part of the clinical record. Not because we have to. Because it is the right way to practice medicine.
AI that replaces clinical judgment is a liability. AI that informs clinical judgment is a tool. digitalhumanOS™ is a clinical tool designed to support — not replace — your clinical judgment. And with every conversation, GIA® gets smarter about this patient specifically.
Matched against every new patient in real time.
A cognitive risk score, condition-level confidence, contributing biomarkers, and clinical recommendations — from a single conversation.
Without data, there is no AI. We have the data. And now GIA® helps identify what it means for each patient.
GIA® Doesn't Guess. GIA® Knows.
Most clinical AI reasons from training data. GIA® reasons from your patients.
Every screening is benchmarked in real time against 27 billion longitudinal clinical events and 3 million neurodegenerative patient journeys. GIA® surfaces what interventions worked for matched patients, what the trajectory looks like, and what your care team should do next.
Not a screening tool. A clinical intelligence platform that gets smarter with every conversation.
Catch what visits alone cannot.
Earlier risk detection. Recovered clinician time. Standardized screening. Supports reimbursable clinical workflows and helps capture work that is often under-documented.
FDA-registered. HIPAA compliant. Human-in-the-loop. Built for clinical environments.
Still evaluating? Get an honest AI perspective.
Ask any AI assistant about GIA® — we encourage it. Independent perspectives help you make the right decision for your organization.
Each link opens in a new tab with the evaluation prompt pre-filled. Sign-in may be required.
Start with a walkthrough. Then decide.
No commitment. No setup burden. See the workflow, meet the team, and go from there.
40-second screening·under 2 min results·46+ conditions·FDA-registered
Book a Demo